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In Europe, the emergence and spread of antibiotic resistance (AMR) has become a serious 
public health threat. Rational antibiotic policy, combined with enforcement of infection 
control practices are key strategies to combat AMR in the hospital setting. Using time-
series analysis, we calculated potential savings resulting from changes in prescribing 
behaviour and improved compliance with hand hygiene. According to our calculations, a 
saving of 14 € would be achieved by reducing use of third-generation cephalosporins by 
one defined daily dose and further savings of almost 60 € would be achieved by increasing 
hospital-wide use of alcohol-based hand rub by one litre. 
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Introduction 
In the past decades, antibiotic resistance (AMR) in pathogenic bacteria has been a growing 
problem both in Europe and worldwide. The race against resistance began soon after 
penicillin was developed. When with the emergence and spread of resistant organisms 
penicillin began to lose effectiveness, scientists dealt with the problem by developing 
methicillin, a synthetic penicillin; however, that agent, too, soon began to lose 
effectiveness.
1 Thus, new classes of antimicrobial agents were developed to replace 
methicillin. Now, as development has slowed down the effectiveness of antibiotics in 
general is beginning to decline.
2;3 
From a public health perspective, the effectiveness of antibiotic agents in hospital settings 
may be seen as a natural resource that is (1) protected by infection control practices 
implemented to prevent cross-transmission of resistant bacteria and (2) exploited by the 
use of antibiotics. Antibiotic use gives antibiotic-resistant bacterial strains a comparative 
advantage to spread, resulting in a direct correlation between the volume of antibiotic 
consumption and the spread of resistance in hospital settings, as 3 recent studies using 
time-series analysis have shown.
4-6  
Studies using time-series analyses on a hospital-wide level have shown that temporal 
increases (decreases) in the use of some classes of antibiotics are followed by temporal 
increases (decreases) in the incidence of methicillin-resistant Staphylococcus aureus 
(MRSA), the most prominent multi-drug resistant pathogen. Furthermore, these studies 
have also shown that infection control practices such as hand disinfection are able to 
decrease MRSA incidence.
4-6  
Loss of antibiotic activity as a direct result of antibiotic consumption can be modelled on 
the approach of a negative externality. According to this concept, the cost of resistance is 
considered to be a negative externality of antibiotic use.
7;8 The study-objective was to 
determine the externalities of four classes of antibiotics which scientifically influence the 




The externality determines the level of the cost of resistance that is caused by use of one 
defined daily dose (DDD) of a selected antibiotic. Therefore, knowledge of the extent to 
which an antibiotic may have contributed to the emergence of resistance and what costs 
are incurred by which type of resistant infection is imperative. Following existing approaches, the probability of the failure of antibiotic treatment due to 
a resistant organism is termed R, while the additional cost of infections caused by resistant 
bacteria are represented by Δ . The impact parameter between antibiotic use and the 
occurrence of resistance 
V
ε  is called dose-response rate of drug use – drug resistance and 
may be described as the percentage change in the incidence of resistance following a 1% 
change in the level of antibiotic use.
8 The externality E of the use of antibiotic q is then 
given by  
( 1 )         ε = Δ qq q ER V , 
where the negative externality is determined by the linear relationship between antibiotic 
use and the occurrence of resistance ε , the probability of the acquisition of a resistant 
infection R and the constant costs of an infection caused by a resistant pathogen  .  ΔV
The data 
In one of our previous studies, the impact of antibiotic use on the incidence of nosocomial 
MRSA infections was determined using a multivariate linear regression model.
5 There was 
a positive impact for the use of second-generation cephalosporins (coeff.= 1.41, p = 0.023), 
third-generation cephalosporins (coeff.=  1.03, p  =  0.051), fluoroquinolones (coeff.=  1.12, 
p  =  0.01) and lincosamides (coeff.=  0.42, p  =  0.05). Since logarithmically transformed 
variables were used in the regression, the dose-response rates ε  equaled the resulting 
coefficients, which means that a one percent increase in third-generation cephalosporin 
use was followed by a 1.03 percent increase in the number of nosocomial MRSA infections. 




The study was conducted at University Medical Center Freiburg, a 1600 bed tertiary care 
teaching hospital. During the study period (January 2003 through October 2007), the 
mean monthly number of episodes of nosocomial infection was identified as being 2.69. 
Monthly antibiotic use is shown in Table 1. The probability of treatment-failure due to a 
resistant organism was calculated by using the  monthly number of nosocomial MRSA 
infections in relation to the amount of antibiotics used.( MRSA DDD ∑ ∑ ; see Table 1).  
Presuming that the additional cost of an MRSA-patient is significantly higher (8198€) than 
that of a non-MRSA patient,
10 the calculations shown in Table 1 demonstrate the extent of 
the external cost of antibiotic consumption from promoting resistance.  
2 3 
(Insert Table 1 here) 
Equally, equation (1) can be used to determine the positive effect of hand disinfection. 
Using existing data,
5 we integrated the series of alcohol-based hand rub use into our 
multivariate  model  (coeff.= -5.37,  p < 0.001).  The negative coefficient estimated in the 
model shows the preventive impact of alcohol-based hand rub use on the incidence of 
MRSA. The results obtained from including alcohol-based hand rub use in equation (1) is 
shown in Table 1 and may be seen as the potential costs prevented by use of one litre of 
alcohol-based hand rub solution for hand disinfection. In other words, using only 3ml 
alcohol-based hand rub solution for hand disinfection, saves 0.18€ of the potential cost 
incurred by MRSA-related infections. 
Discussion 
As of yet, there are few studies demonstrating that use of antibiotics leads to indirect 
external costs by promoting resistance.
7;8 
Although, the estimates presented here for the externality of antibiotic use are crude, they 
demonstrate that antibiotic consumption does from the perspective of a hospital, at least, 
substantially affect the cost of resistance. An externality of around 10 € per DDD is a small 
amount of money compared to the overall per diem cost of hospitalization, but is a 
significant amount compared to the direct cost of the antibiotic.  
According to our calculations, a saving of approximately 14 € would be achieved by 
reducing use of third-generation cephalosporins by a single DDD. Increasing hospital-wide 
use of alcohol-based hand rub by one litre would give a saving of approximately 60 €. The 
emergence and spread of resistance in hospital settings is a multifactor process. Thus, 
prevention of AMR in the hospital can be only achieved by taking a multifactor approach in 
changing the major variables antibiotic use and infection control practice, especially hand 
hygiene. Both variables were tested in the multivariate time-series analysis.
5 
Demonstrating the net benefit of preventing AMR may lead to changes in prescribing 
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 Table 1: Characteristics of the parameters used for the determination of the externality 
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MRSA DDD ∑ ∑
c  ε
d  V Δ
e  E 
f
on  6544 0.0004111  1.41  8 198 € 4.75  €  second-generati
cephalosporins 
third-generation  1627 0.0016534 1.03 8 198 € 13.96  € 




fluoroquinolon 2352 0.0011437 1.12 8 198 € 10.50  € 
lincosamides 840  0.0032024 0.42 8 198 € 11.03  € 
alcohol-based hand rub  1991  0.0013511 -5.37 8 198 € -5
aUses of antibiotics and alcohol-based hand rub solution as included in the multivariate analysis. 
bMonthly amounts of antibiotic use (in DDD) and alcohol-based hand rub use (in litres) during the study 
ent study in 11 German hospitals.
10 
period (01/2003 – 10/2007). 
cThe probability of the acquisition of a resistant infection. 
dDose-response rate of drug use – drug resistance as determined in the multivaria e analysis.  t
eThe additional costs of an Infection due to MRSA according to a rec
fThe externality E of the use of one unit of q according to equation  qq q ER V ε = Δ . 
gThe externality of alcohol-based hand rub use may be seen as potential costs prevented by one litre of 
alcohol-based hand rub use for hand disinfection. Seit 2005 erschienene Beiträge 
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